We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
The signs of foot and mouth disease, what to do if you suspect it in your animals and measures to prevent its spread.
How to spot lumpy skin disease, what to do if you suspect it and how to prevent it spreading.
How to spot equine viral encephalomyelitis, what to do if you suspect it and how to prevent it spreading.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
How to spot epizootic lymphangitis, what to do if you suspect it and measures to prevent its spread.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
How to spot contagious equine metritis, what to do if you suspect it and measures to prevent its spread.
Product Safety Report for Wau Wa Eczema Herbal Cream presenting a serious chemical risk.
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).